MBX Biosciences (MBX) Amortizatization of Intangibles (2023 - 2026)

MBX Biosciences has disclosed Amortizatization of Intangibles across 4 years of filings, most recently posting $579000.0 for Q1 2026.

• Amortizatization of Intangibles for Q1 2026 came in at $579000.0, down 56.89% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.8 million (down 24.44% YoY), and the FY2025 annual result was $3.6 million, up 23.33% from the prior year.
• Amortizatization of Intangibles came in at $579000.0 for Q1 2026 at MBX Biosciences, up from $555000.0 in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $1.4 million in Q4 2024 to a low of $441000.0 in Q2 2024.
• The 4-year median for Amortizatization of Intangibles is $593500.0 (2023), against an average of $771800.0.
• Peak annual rise in Amortizatization of Intangibles reached 167.0% in 2025, while the deepest fall reached 60.27% in 2025.
• MBX Biosciences' Amortizatization of Intangibles stood at $600000.0 in 2023, then surged by 132.83% to $1.4 million in 2024, then slumped by 60.27% to $555000.0 in 2025, then gained by 4.32% to $579000.0 in 2026.
• The last three Amortizatization of Intangibles figures came in at $579000.0 (Q1 2026), $555000.0 (Q4 2025), and $734000.0 (Q3 2025), per Business Quant data.